Our R&D programmes focus on the development of prognostic and predictive glycomic blood biomarkers and Immunofrailty Model. These innovations will enable early detection and treatment personalisation for Inflammatory conditions in clinical practice.
How Immunofrail are you?
Glycan-based test that measures the fitness of your immune system from a small amount of blood.
The answer is in your gut!
Prognostic and predictive biomarker to support clinical decision-making in Inflammatory Bowel Disease.
Superior biomarker for CI
Exploratory studies demonstrated that our GlyHealth-Index measure general Chronic Inflammation is superior to other commonly used biomarkers.